[{"quiz_id": "ABMS20260101_deepseek-v3.2_p01", "question_id": "ABMS20260101_deepseek-v3.2_p01-001", "question": "A 5-week-old term infant presents with extreme irritability, brisk pupillary light reflexes, and episodic generalized hypertonia with arching of the back. There is reportedly bilious vomiting after feeds and undigested formula in loose stools. Testing reveals a severe hyponatremia (115 mEq/L), hypochloremia, and hyperkalemia with severe metabolic acidosis. Ultrasound shows bladder wall thickening with bilateral hydroureteronephrosis but no posterior urethral valves. Plasma renin activity is markedly elevated, and serum cortisol is normal. Which of the following electrolyte management strategies is most specifically appropriate pending definitive diagnosis?", "options": ["Isotonic saline boluses followed by fluid restriction to prevent sodium loss", "Hypertonic saline with sodium polystyrene sulfonate and sodium bicarbonate", "Isotonic saline with fludrocortisone to promote renal sodium reabsorption", "Normal saline boluses and maintenance fluids with added sodium bicarbonate and potassium chloride", "Withhold all sodium and potassium, provide glucose-only intravenous fluids to minimize tubular electrolyte load"], "answer": "B", "answer_index": 1, "explanation": "This infant has classic pseudohypoaldosteronism type 1 (autosomal recessive multiple organ form) due to mutations in the epithelial sodium channel (ENaC) subunits. The key is severe renal salt-wasting with hyperkalemia and metabolic acidosis despite elevated aldosterone/renin. Correction requires hypertonic saline for severe hyponatremia, sodium polystyrene sulfonate for hyperkalemia, and sodium bicarbonate for acidosis. Fludrocortisone is ineffective since the defect is in the aldosterone receptor/target. Saline alone worsens potassium and acidosis; glucose-only fluids would exacerbate hyponatremia and shock.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "source_question_id": "20251219T221819110Z_deepseek-v3.2_seed132-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251219T221819110Z_deepseek-v3.2_seed132", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251219T221819110Z_deepseek-v3.2_seed132.jsonl", "pred": "B", "model_outputs": "This patient presents with a classic \"salt-wasting\" crisis characterized by severe hyponatremia, hyperkalemia, and metabolic acidosis. The combination of these electrolyte disturbances with markedly elevated plasma renin activity and normal serum cortisol typically narrows the differential diagnosis to disorders of aldosterone deficiency (e.g., aldosterone synthase deficiency) or aldosterone resistance (Pseudohypoaldosteronism).\n\nThe key distinguishing feature provided in the clinical scenario is the finding of bladder wall thickening with bilateral hydroureteronephrosis in the absence of posterior urethral valves. This constellation of findings is highly characteristic of Pseudohypoaldosteronism Type 1 (PHA1). In PHA1, chronic polyuria (due to obligate sodium and water loss) often leads to functional urinary tract dilation that mimics obstructive uropathy.\n\nBecause PHA1 is caused by end-organ resistance to mineralocorticoids (either a defect in the Mineralocorticoid Receptor in the renal form, or the ENaC channel in the systemic form), administration of exogenous mineralocorticoids like fludrocortisone (Option C) is ineffective.\n\nThe appropriate management for PHA1 involves aggressive sodium replacement and management of hyperkalemia.\n*   Option A is incorrect because fluid restriction is contraindicated in a salt-wasting state; it would exacerbate hypovolemia and shock.\n*   Option B is the best answer. The patient has severe symptomatic hyponatremia (115 mEq/L with irritability and hypertonia), which justifies the use of hypertonic saline or aggressive sodium supplementation to safely raise serum sodium. Sodium polystyrene sulfonate (Kayexalate) is used to lower the dangerous hyperkalemia, and sodium bicarbonate addresses the metabolic acidosis. This strategy treats the electrolyte derangements directly, which is necessary due to hormonal resistance.\n*   Option C is incorrect because fludrocortisone will not work in a patient with mineralocorticoid resistance (PHA1).\n*   Option D is contraindicated because it includes Potassium Chloride, which would be lethal in a patient with hyperkalemia.\n*   Option E is lethal as it provides no sodium to a salt-wasting patient.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p01", "question_id": "ABMS20260101_deepseek-v3.2_p01-002", "question": "A 68-year-old man presents to the ED with acute onset of 'rice-water' diarrhea profuse enough to require intravenous fluid resuscitation. He returned yesterday from a coastal business trip. Stool studies are positive for non-O1, non-O139 Vibrio cholerae. Despite aggressive volume repletion, he develops acute renal failure and profound metabolic acidosis with an anion gap of 28. Which specific toxin-mediated mechanism explains the renal failure pattern?", "options": ["Shiga-like toxin causing hemolytic uremic syndrome", "Heat-stable enterotoxin inducing prerenal azotemia", "RTX toxin causing direct tubular epithelial necrosis", "Zonula occludens toxin leading to ischemic acute tubular necrosis", "Cholera toxin-like effect with profound hypovolemia"], "answer": "C", "answer_index": 2, "explanation": "Non-O1, non-O139 V. cholerae produces RTX (repeats in toxin) toxin which has direct cytotoxic effects on renal tubular epithelium, distinguishing it from classic cholera's pure secretory diarrhea. This explains the development of intrinsic renal failure despite adequate volume repletion. Shiga toxin is produced by enterohemorrhagic E. coli, not Vibrio species. The metabolic acidosis reflects both the diarrhea losses and renal failure.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "target_topic", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "source_question_id": "20251216T183904770Z_deepseek-v3.2_seed128-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251216T183904770Z_deepseek-v3.2_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T183904770Z_deepseek-v3.2_seed128.jsonl", "pred": "E", "model_outputs": "This question describes a patient with Cholera-like illness caused by non-O1, non-O139 *Vibrio cholerae*. The clinical presentation of \"rice-water diarrhea\" profuse enough to cause shock and require resuscitation is characteristic of the action of Cholera Toxin (CT) or a very similar enterotoxin. While non-O1/non-O139 strains are serologically distinct from the pandemic strains, some acquire the virulence genes (like *ctxAB*) via phage transfer and produce a toxin functionally and immunologically identical to CT. Others may produce a heat-stable enterotoxin (NAG-ST) that also causes severe secretory diarrhea.\n\n1.  Renal Failure Pattern: The patient has developed Acute Renal Failure (ARF) with a High Anion Gap (AG = 28) metabolic acidosis.\n    *   In early or mild cholera, the acidosis is typically a Normal Anion Gap (hyperchloremic) metabolic acidosis due to the massive loss of bicarbonate in the stool.\n    *   However, in severe cases with profound hypovolemia and shock, patients develop Acute Tubular Necrosis (ATN) due to ischemia.\n    *   The development of ATN leads to the retention of uremic toxins (phosphates, sulfates, etc.) and the hypovolemic shock leads to the accumulation of lactate. Both uremia and lactic acidosis cause a High Anion Gap metabolic acidosis.\n    *   The prompt specifies that the renal failure persisted despite volume repletion, confirming intrisic renal failure (ATN) rather than prerenal azotemia.\n\n2.  Evaluating the Options:\n    *   A. Shiga-like toxin causing HUS: This is associated with EHEC (*E. coli* O157:H7) and *Shigella*, not *Vibrio cholerae*.\n    *   B. Heat-stable enterotoxin inducing prerenal azotemia: While some non-O1 strains produce NAG-ST, the renal pathology described is intrinsic failure (ATN), not responsive to fluids (not prerenal). Prerenal azotemia would correct with fluids.\n    *   C. RTX toxin causing direct tubular epithelial necrosis: While RTX toxins are cytotoxic, the mechanism of renal failure in cholera is overwhelmingly ischemic (preventable/treatable by perfusion) rather than a direct nephrotoxic hit by a systemic toxin. The \"rice-water\" clinical picture points to volume depletion as the primary insult.\n    *   D. Zonula occludens toxin (Zot): Zot increases intestinal permeability but is a minor contributor compared to CT, and there is no evidence it causes direct ischemic ATN independent of the profound hypovolemia caused by the main enterotoxin.\n    *   E. Cholera toxin-like effect with profound hypovolemia: This correctly identifies the primary pathophysiology. The enterotoxin (CT or CT-like) causes massive fluid loss (\"rice-water\" stool). This leads to profound hypovolemia, which causes severe renal ischemia, resulting in Acute Tubular Necrosis (ATN). The ATN and shock explain the high anion gap acidosis.\n\nThe answer is (E)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p01", "question_id": "ABMS20260101_deepseek-v3.2_p01-003", "question": "A 32-year-old G2P1001 at 31 weeks gestation presents with acute-onset severe abdominal pain and hypotension. Ultrasound shows a normal intrauterine pregnancy with fetal heart rate 140 bpm, but a large right adnexal complex mass with free fluid. She is taken emergently to OR for suspected ovarian torsion. Intraoperatively, the right ovary is necrotic and detorted but appears hemorrhagic with surface excrescences. Frozen section returns 'atypical cells, cannot rule out malignancy.' Which of the following is the most appropriate surgical management?", "options": ["Right oophorectomy only, preserve uterus and left adnexa", "Right oophorectomy with right pelvic lymph node sampling", "Right oophorectomy with infracolic omentectomy and pelvic washings", "Right salpingo-oophorectomy with left ovarian biopsy and appendectomy", "Proceed with total abdominal hysterectomy with bilateral salpingo-oophorectomy"], "answer": "C", "answer_index": 2, "explanation": "In pregnancy with suspected ovarian cancer, staging should be as complete as possible while preserving the pregnancy. Omentectomy and washings provide critical staging information without compromising uterine blood supply or requiring extensive dissection near the gravid uterus. Lymph node sampling is not recommended in pregnancy due to risk of hemorrhage near iliac vessels; full lymphadenectomy can wait until postpartum. Appendectomy is only indicated for mucinous tumors. Hysterectomy terminates pregnancy unnecessarily; ovarian biopsy of normal ovary is not indicated. Frozen section limitations necessitate complete staging for definitive management decisions.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "target_topic", "source_label_raw": "Obstetrics and Gynecology", "source_quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "source_question_id": "20251219T221819110Z_deepseek-v3.2_seed132-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251219T221819110Z_deepseek-v3.2_seed132", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251219T221819110Z_deepseek-v3.2_seed132.jsonl", "pred": "A", "model_outputs": "This clinical scenario describes a pregnant patient (31 weeks) with an acute abdomen due to ovarian torsion of a suspicious likely necrotic mass. The key decision points involve balancing the management of the acute surgical emergency, the suspicion of malignancy, the ambiguity of the frozen section, and the safety of the fetus and mother.\n\n1.  Diagnosis and Immediate Action: The patient has a necrotic ovary due to torsion. The non-viable tissue must be removed to prevent sepsis and hemorrhage. Detorsion alone is insufficient due to necrosis. Therefore, removal of the right adnexa (oophorectomy/salpingo-oophorectomy) is required.\n2.  Pathology and Staging: The frozen section shows \"atypical cells\" but does not confirm invasive malignancy. It likely represents a borderline ovarian tumor or the interpretation is limited by necrosis. In a young, fertile patient—especially one who is pregnant—radical surgery (hysterectomy/bilateral salpingo-oophorectomy) is contraindicated without a definitive diagnosis of invasive cancer that necessitates widespread clearance.\n3.  Surgical Constraints of Pregnancy: At 31 weeks, the gravid uterus extends well into the upper abdomen. This makes staging procedures like infracolic omentectomy (Option C) and retroperitoneal lymph node dissection (Option B) technically very difficult, hazardous, and associated with increased morbidity (bleeding, preterm labor). Standard guidelines suggest that for adnexal masses in the third trimester, surgical management should be limited to treating the acute complication (e.g., adnexectomy). Comprehensive staging, if required based on final pathology, can be performed postpartum or at the time of a cesarean section if appropriate.\n4.  Contralateral Ovary: Biopsy of a macroscopically normal contralateral ovary (Option D) is generally contraindicated in young women desiring fertility due to the risk of peritubal adhesions and mechanical infertility, with a very low yield for detecting occult disease.\n5.  Conclusion: The safest and most appropriate management is to remove the affected right ovary (and tube, implied) to treat the torsion and obtain a final diagnosis, while preserving the pregnancy and the normal left adnexa.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p01", "question_id": "ABMS20260101_deepseek-v3.2_p01-004", "question": "A 45-year-old woman with metastatic carcinoid syndrome presents for emergent small bowel obstruction surgery. During anesthesia induction, she develops profound hypotension refractory to fluid boluses and phenylephrine. ECG shows sinus tachycardia with non-specific ST changes. Transesophageal echocardiography reveals global hypokinesis with apical sparing ('takotsubo-like' pattern). Which specific pharmacologic intervention is most appropriate?", "options": ["Intravenous octreotide", "Intravenous corticosteroids", "Intravenous β-blocker", "Intravenous calcium gluconate", "Intravenous methylene blue"], "answer": "A", "answer_index": 0, "explanation": "This describes carcinoid crisis mediated by massive serotonin release, causing both hypotension and catecholamine-mediated myocardial stunning (carcinoid heart disease). Octreotide is the specific antidote that inhibits serotonin release. β-blockers could worsen hypotension and bronchospasm. Corticosteroids might help with refractory shock but are not specific. Calcium and methylene blue have no role in carcinoid crisis management. The apical sparing pattern reflects catecholamine-mediated stunning rather than primary cardiac ischemia.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "abms_specialty": "Anesthesiology", "abms_source": "target_topic", "source_label_raw": "Anesthesiology", "source_quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "source_question_id": "20251216T183904770Z_deepseek-v3.2_seed128-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251216T183904770Z_deepseek-v3.2_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T183904770Z_deepseek-v3.2_seed128.jsonl", "pred": "A", "model_outputs": "This patient with metastatic carcinoid syndrome is presenting with signs of carcinoid crisis, precipitated by the induction of anesthesia and surgery. Carcinoid crisis is a life-threatening complication characterized by profound hemodynamic instability (often hypotension, but sometimes hypertension), flushing, bronchospasm, and arrhythmias. The pathophysiology involves the sudden massive release of vasoactive mediators (serotonin, bradykinin, histamine, kallikrein) from the tumor.\n\nThe clinical presentation described emphasizes profound hypotension that is refractory to fluid boluses and phenylephrine. In carcinoid crisis, the hypotension is often poorly responsive to standard vasopressors, and the administration of beta-adrenergic agonists (like epinephrine or ephedrine) can paradoxically worsen the condition by stimulating further release of tumor mediators. While phenylephrine is an alpha-agonist and generally safer than catecholamines with beta-activity, its failure indicates the need for specific therapy targeting the underlying mediator release.\n\nThe echocardiographic finding of global hypokinesis with apical sparing (\"takotsubo-like\" pattern, or more specifically similar to reverse-takotsubo or stress cardiomyopathy variants) can be associated with acute stress states and high circulating neurohumoral factors, which may occur during a crisis. However, the management priority is to halt the release of the offending mediators.\n\nIntravenous octreotide (a somatostatin analogue) is the specific and most appropriate pharmacologic intervention. It directly inhibits the release of vasoactive peptides from carcinoid tumors. It is the first-line treatment for intraoperative carcinoid crisis to restore hemodynamic stability.\n\nOptions Analysis:\n*   A. Intravenous octreotide: Correct. It prevents the release of vasoactive mediators causing the crisis.\n*   B. Intravenous corticosteroids: Used for carcinoid crisis prevention in some protocols or allergic reactions, but effective treatment for acute hemodynamic collapse in crisis is octreotide.\n*   C. Intravenous β-blocker: May worsen hypotension in the setting of global hypokinesis/myocardial depression and does not stop mediator release.\n*   D. Intravenous calcium gluconate: Used for hypocalcemia or hyperkalemia, not the specific treatment for carcinoid crisis.\n*   E. Intravenous methylene blue: Used for refractory vasoplegia (e.g., post-bypass), but octreotide is the specific antidote for carcinoid-induced vasoplegia/crisis.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p01", "question_id": "ABMS20260101_deepseek-v3.2_p01-005", "question": "A 28-year-old woman with borderline personality disorder presents after ingesting 100 tablets of acetaminophen 500 mg. She presents 30 hours post-ingestion with normal vital signs and normal mental status. AST is 850 U/L, INR is 1.8, creatinine is 1.2 mg/dL. IV N-acetylcysteine (NAC) is initiated. Six hours into the infusion, she develops acute respiratory distress, wheezing, facial edema, and hypotension. After stopping NAC and administering diphenhydramine and methylprednisolone, her symptoms resolve. Her AST has risen to 2,100 U/L. Which of the following is the most appropriate next step?", "options": ["Continue NAC at a reduced rate with diphenhydramine premedication", "Switch to oral NAC 140 mg/kg followed by 70 mg/kg every 4 hours", "Begin high-flux hemodialysis to remove acetaminophen and NAC", "Administer cimetidine 300 mg IV every 6 hours as NAC alternative", "Initiate IV L-ornithine L-aspartate and silibinin as hepatoprotective agents"], "answer": "B", "answer_index": 1, "explanation": "Oral NAC is equally effective as IV for acetaminophen toxicity and should be used when IV causes anaphylactoid reactions. Continuing IV NAC with premedication risks recurrent reaction and hypotension. Hemodialysis does not effectively remove acetaminophen or NAC metabolites. Cimetidine has limited evidence and insufficient hepatoprotection. L-ornithine and silibinin are unproven in acute overdose. Since the patient presented late with established hepatotoxicity, completion of NAC via oral route is critical for glutathione repletion despite initial reaction to IV formulation.", "generator_model": "deepseek-v3.2", "seed": 132, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251219T221819110Z_deepseek-v3.2_seed132", "source_question_id": "20251219T221819110Z_deepseek-v3.2_seed132-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251219T221819110Z_deepseek-v3.2_seed132", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251219T221819110Z_deepseek-v3.2_seed132.jsonl", "pred": "B", "model_outputs": "This patient has presented with significant acetaminophen toxicity (hepatotoxicity and coagulopathy) and requires N-acetylcysteine (NAC) therapy. During the IV NAC infusion, she developed a severe anaphylactoid reaction characterized by respiratory distress, facial edema, and hypotension.\n\nThe management of NAC-induced anaphylactoid reactions involves stopping the infusion and treating the symptoms (as was done). Once the reaction has resolved, the clinician must decide how to continue the necessary antidotal therapy.\n\n1.  Assessment of Severity: The patient's reaction was severe (hypotension and respiratory distress).\n2.  Feasibility of Alternative Route: The patient has a normal mental status, which implies that her airway reflexes are intact and she can tolerate oral medication.\n3.  Choice of Strategy:\n    *   Restarting IV NAC (Option A): While restarting IV NAC at a slower rate is an option for mild-to-moderate reactions (e.g., flushing, urticaria), it is hazardous after a severe reaction involving hemodynamic instability (hypotension) or airway compromise.\n    *   Switching to Oral NAC (Option B): Current toxicology guidelines and major references (e.g., Goldfrank's Toxicologic Emergencies, UpToDate) recommend switching to oral NAC for patients who experience severe anaphylactoid reactions to the IV preparation, provided they can tolerate oral administration (i.e., no ileus, obstruction, or aspiration risk). Oral NAC rarely causes anaphylactoid reactions. The dosing regimen in Option B (140 mg/kg loading dose followed by 70 mg/kg every 4 hours) is the correct standard protocol for oral NAC.\n\nOptions C, D, and E are incorrect:\n*   Hemodialysis (Option C) is reserved for massive ingestions with massive levels, severe metabolic acidosis, and mitochondrial dysfunction, or established fulminant hepatic failure requiring renal support. It is not the immediate next step solely due to an NAC reaction.\n*   Cimetidine (Option D) is not a standard antidote for acetaminophen toxicity.\n*   L-ornithine L-aspartate and silibinin (Option E) are not standard replacements for NAC in the acute management of acetaminophen poisoning.\n\nTherefore, switching to oral NAC is the safest and most appropriate next step to ensure the patient receives the antidote without risking recurrent anaphylaxis.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p01", "question_id": "ABMS20260101_deepseek-v3.2_p01-006", "question": "During laparoscopic Roux-en-Y gastric bypass, a surgeon encounters dense adhesions from previous open cholecystectomy. While adhesiolysing near the liver hilum, brisk arterial bleeding occurs from a structure posterior to the common bile duct. What is the most likely injured vessel and appropriate management?", "options": ["A. Proper hepatic artery; laparoscopic suture repair", "B. Right hepatic artery; conversion to laparotomy for repair", "C. replaced right hepatic artery; angiographic embolization", "D. Gastroduodenal artery; clip application", "E. Cystic artery stump; electrocautery"], "answer": "B", "answer_index": 1, "explanation": "Bleeding posterior to the common bile duct typically indicates injury to the right hepatic artery, which courses behind the duct in most patients. This requires immediate conversion to laparotomy for direct vascular repair due to the caliber of the vessel and risk of hepatic ischemia. Laparoscopic control is difficult and risky. The replaced right hepatic artery originates from the SMA and is not typically in this location during gastric bypass dissection.", "generator_model": "deepseek-v3.2", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "abms_specialty": "General Surgery", "abms_source": "target_topic", "source_label_raw": "General Surgery", "source_quiz_id": "20251216T183904770Z_deepseek-v3.2_seed129", "source_question_id": "20251216T183904770Z_deepseek-v3.2_seed129-012", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251216T183904770Z_deepseek-v3.2_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T183904770Z_deepseek-v3.2_seed129.jsonl", "pred": "B", "model_outputs": "This question tests anatomical knowledge of the hepatic hilum and surgical judgment regarding the management of intraoperative vascular injuries.\n\n1.  Anatomical Identification: The question describes brisk arterial bleeding from a structure posterior to the common bile duct (or common hepatic duct) during lysis of adhesions from a previous cholecystectomy.\n    *   The Proper Hepatic Artery typically runs medial to the common bile duct.\n    *   The Right Hepatic Artery (RHA) (standard anatomy) arises from the proper hepatic artery and crosses posterior to the common hepatic/bile duct in approximately 85-90% of individuals to reach the right lobe of the liver. This makes it the structure most likely to be encountered and injured in the described location, especially when anatomy is distorted by scarring.\n    *   A Replaced Right Hepatic Artery (arising from the SMA) typically ascends in the hepatoduodenal ligament posterolateral (to the right) of the bile duct and usually does not cross behind it in the same manner as the conventional RHA.\n    *   The Gastroduodenal Artery is generally inferior to this area.\n\n2.  Management Strategy:\n    *   Right Hepatic Artery Injury: Injury to the RHA carries risks of hepatic ischemia (though often tolerated due to portal flow) and, more critically, biliary ischemia, which can lead to strictures or breakdown of biliary enteric anastomoses. Therefore, repair is generally advocated if feasible.\n    *   Surgical Approach: While laparoscopic skills vary, encountering brisk hemorrhage from a major hepatic artery in a field with \"dense adhesions\" represents a surgical emergency where visualization is compromised. Attempting laparoscopic suture repair (Option A) in a bloody, scarred field is highly hazardous and risks further injury to the bile duct or portal vein. The standard of care and the safest answer for board examinations is conversion to laparotomy to obtain proximal and distal control and perform a microsurgical repair or safe ligation if repair is impossible.\n    *   Angiographic embolization (Option C) is appropriate for hemodynamically stable patients with postoperative bleeding or pseudoaneurysms, not for immediate intraoperative control of brisk bleeding.\n    *   Electrocautery (Option E) near the common bile duct is contraindicated due to the high risk of thermal injury and stricture formation.\n\nConclusion: The vessel located posterior to the common bile duct is the Right Hepatic Artery. The appropriate management for a major vascular injury in a complex, non-visualized laparoscopic field is conversion to laparotomy for repair.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p01", "question_id": "ABMS20260101_deepseek-v3.2_p01-007", "question": "A 72-year-old diabetic man presents with sudden painless vision loss in his right eye to counting fingers. Examination reveals a relative afferent pupillary defect, diffusely cloudy cornea, shallow anterior chamber, and intraocular pressure of 55 mmHg. The fellow eye has a deep anterior chamber with open angles. What is the most definitive management?", "options": ["A. Immediate anterior chamber paracentesis", "B. Systemic carbonic anhydrase inhibitors and topical beta-blockers", "C. Laser peripheral iridotomy in the affected eye", "D. Lens extraction via phacoemulsification", "E. Endothelial keratoplasty combined with trabeculectomy"], "answer": "D", "answer_index": 3, "explanation": "This describes phacomorphic glaucoma where an intumescent cataract causes pupillary block and angle closure. Unlike primary angle closure, laser iridotomy is insufficient because the mechanism is lens-related. Lens extraction resolves the underlying anatomic problem. Medical management may temporize but is not definitive. The unaffected fellow eye with open angles confirms this is not bilateral anatomic narrow angles.", "generator_model": "deepseek-v3.2", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "abms_specialty": "Ophthalmology", "abms_source": "target_topic", "source_label_raw": "Ophthalmology", "source_quiz_id": "20251216T183904770Z_deepseek-v3.2_seed129", "source_question_id": "20251216T183904770Z_deepseek-v3.2_seed129-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251216T183904770Z_deepseek-v3.2_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T183904770Z_deepseek-v3.2_seed129.jsonl", "pred": "D", "model_outputs": "The clinical presentation of a 72-year-old diabetic man with a unilateral shallow anterior chamber, high intraocular pressure (55 mmHg), and a cloudy cornea, combined with the crucial finding of a deep anterior chamber with open angles in the fellow eye, is classic for Phacomorphic Glaucoma.\n\nHere is the reasoning:\n1.  Diagnosis: The asymmetry in anterior chamber depth rules out Primary Angle Closure Glaucoma (which is associated with bilateral narrow angles). A unilateral shallow chamber with high IOP suggests a secondary mechanism, specifically a \"pushing\" mechanism from behind the iris. In an elderly diabetic patient, the most common cause is an intumescent (swollen) cataract pushing the iris forward and closing the angle. This is Phacomorphic Glaucoma.\n2.  Symptoms: The \"sudden painless vision loss\" can be attributed to the rapid development of the intumescent cataract and the subsequent corneal edema from high IOP. The lack of pain, which is atypical for acute angle closure (usually severe pain, nausea, vomiting), is often explained in board vignettes by diabetic neuropathy or the elderly status of the patient (unreported or blunted sensation).\n3.  Signs: The Relative Afferent Pupillary Defect (RAPD) suggests significant optic nerve compromise or retinal ischemia, likely secondary to the extremely high IOP or underlying diabetic retinal pathology.\n4.  Management:\n    *   Medical therapy (Option B) is the *initial* step to lower IOP and clear the cornea, but it is not definitive as the anatomical cause (the swollen lens) remains.\n    *   Laser Peripheral Iridotomy (Option C) is the definitive treatment for *Primary* Angle Closure. In phacomorphic glaucoma, it may relieve the pupillary block component, but the angle often remains crowded by the bulky lens. It is not the definitive cure.\n    *   Paracentesis (Option A) is temporizing and risky.\n    *   Lens extraction (Option D) removes the swollen lens, which is the root cause of the angle closure. This deepens the anterior chamber and restores angle patency. Therefore, it is the most definitive management.\n\nThe answer is (D)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p01", "question_id": "ABMS20260101_deepseek-v3.2_p01-008", "question": "A 24-year-old collegiate wrestler sustains a traumatic knee dislocation during competition. After emergent reduction, neurovascular examination reveals absent dorsalis pedis and posterior tibial pulses with a cool, pale foot. CT angiography confirms popliteal artery occlusion. What is the optimal timing for vascular repair relative to ligament reconstruction?", "options": ["A. Immediate vascular repair with delayed ligament reconstruction", "B. Combined single-stage vascular and ligament reconstruction", "C. Vascular repair after ligament reconstruction to stabilize joint", "D. Endovascular stenting followed by ligament reconstruction", "E. Four-compartment fasciotomy with delayed vascular assessment"], "answer": "A", "answer_index": 0, "explanation": "In knee dislocation with vascular injury, limb salvage requires immediate vascular repair (within 6 hours) to prevent irreversible ischemia. Ligament reconstruction should be delayed until soft tissue swelling resolves and range of motion returns, typically 2-3 weeks later. Combined procedures increase complexity and ischemia time. Endovascular approaches are contraindicated in traumatic injuries near joint spaces.", "generator_model": "deepseek-v3.2", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "abms_specialty": "Orthopedic Surgery", "abms_source": "target_topic", "source_label_raw": "Orthopedic Surgery", "source_quiz_id": "20251216T183904770Z_deepseek-v3.2_seed129", "source_question_id": "20251216T183904770Z_deepseek-v3.2_seed129-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251216T183904770Z_deepseek-v3.2_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T183904770Z_deepseek-v3.2_seed129.jsonl", "pred": "A", "model_outputs": "Here is the step-by-step analysis to arrive at the correct answer:\n\n1.  Identify the Clinical Priority: The patient presents with a knee dislocation complicated by popliteal artery injury, evidenced by absent distal pulses and a cool, ischemic foot (Class III ischemia). The immediate priority is limb salvage. Irreversible tissue damage (muscle and nerve) begins within 6 hours of warm ischemia. Therefore, revascularization must be performed urgently.\n\n2.  Evaluate Vascular Management: The gold standard for traumatic popliteal artery occlusion, especially in a mobile joint like the knee, is open surgical repair (usually using a contralateral saphenous vein interposition graft). Endovascular stenting (Option D) is generally contraindicated in the popliteal fossa for young, active patients due to the high risk of stent fracture and thrombosis caused by joint mobility.\n\n3.  Evaluate Orthopedic Management: While the knee joint must be stabilized to protect the vascular repair, definitive ligament reconstruction is a complex, lengthy procedure. Performing it in the acute setting (immediately after injury) is associated with high risks of arthrofibrosis (stiffness), wound complications, and compartmental syndrome due to severe soft tissue swelling.\n\n4.  Combine the Strategies: Standard trauma protocols dictate that the vascular repair takes precedence to restore blood flow. The joint is typically stabilized provisionally (e.g., with an external fixator) during the same anesthesia to protect the vascular graft. Definitive ligament reconstruction is delayed (usually 2-3 weeks or more) until the vascular repair is stable, soft tissue swelling has subsided, and the risk of compartment syndrome has passed.\n\n5.  Analyze the Options:\n    *   A: Correctly prioritizes immediate revascularization to save the leg and safely delays the elective ligament work.\n    *   B: Increases operative time and trauma, heightening the risk of complications like compartment syndrome and graft failure.\n    *   C: Would prolong ischemia time, likely resulting in amputation.\n    *   D: Stenting is not the standard of care for this injury, and immediate ligament reconstruction is ill-advised.\n    *   E: Fasciotomy is often necessary to treat/prevent reperfusion injury, but \"delayed vascular assessment\" is incorrect when occlusion is already confirmed; immediate repair is needed.\n\nTherefore, the optimal management is immediate vascular repair to salvage the limb, with stabilization of the knee, followed by delayed ligament reconstruction.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p01", "question_id": "ABMS20260101_deepseek-v3.2_p01-009", "question": "A 58-year-old man with metastatic renal cell carcinoma on nivolumab and ipilimumab combination therapy presents with acute respiratory failure requiring mechanical ventilation. Bronchoalveolar lavage shows lymphocytic predominance without infectious organisms. High-dose methylprednisolone (2 mg/kg/day) was initiated 72 hours ago without improvement. Which of the following is the most appropriate next step in management?", "options": ["Add infliximab 5 mg/kg single dose", "Initiate cyclophosphamide 1 g/m² IV", "Switch to dexamethasone 40 mg daily", "Begin plasma exchange therapy", "Add tocilizumab 8 mg/kg IV"], "answer": "A", "answer_index": 0, "explanation": "For steroid-refractory immune checkpoint inhibitor-related pneumonitis, TNF-alpha inhibition with infliximab is the recommended next-line therapy based on retrospective evidence showing improved outcomes. Cyclophosphamide is used for other immune-related adverse events like myocarditis but not first-line for pneumonitis. Switching corticosteroids is unlikely to help if already on high-dose methylprednisolone. Plasma exchange is not established for this condition. Tocilizumab (IL-6 inhibitor) is used for cytokine release syndrome but not specifically for checkpoint inhibitor pneumonitis.", "generator_model": "deepseek-v3.2", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Critical Care Medicine", "abms_specialty": "Critical Care Medicine", "abms_source": "topics_mapped", "source_label_raw": "critical care", "source_quiz_id": "20251205T084024622Z_deepseek-v3.2_seed126", "source_question_id": "20251205T084024622Z_deepseek-v3.2_seed126-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251205T084024622Z_deepseek-v3.2_seed126", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251205T084024622Z_deepseek-v3.2_seed126.jsonl", "pred": "A", "model_outputs": "This patient has developed Grade 4 (life-threatening, requiring ventilation) checkpoint inhibitor-associated pneumonitis (CIP) while on combination immunotherapy (nivolumab and ipilimumab). He has been treated with high-dose corticosteroids (methylprednisolone 2 mg/kg/day) for 72 hours without clinical improvement, which defines the condition as steroid-refractory pneumonitis.\n\nAccording to major clinical practice guidelines (e.g., ASCO, NCCN, SITC, ESMO) for the management of immune-related adverse events (irAEs):\n\n1.  First-line: High-dose corticosteroids (e.g., Methylprednisolone 1–2 mg/kg/day).\n2.  Second-line (Steroid-refractory): If there is no improvement after 48–72 hours, additional immunosuppression should be added. The most commonly recommended agents are infliximab (anti-TNF-alpha), mycophenolate mofetil (MMF), or IVIG.\n3.  Third-line: If the patient remains refractory to the above, agents like cyclophosphamide (an alkylating agent) may be considered.\n\nLooking at the options:\n*   Option A (Add infliximab 5 mg/kg single dose): This is a standard guideline-recommended intervention for steroid-refractory pneumonitis. Infliximab works rapidly, which is crucial for a mechanically ventilated patient.\n*   Option B (Initiate cyclophosphamide 1 g/m² IV): While cyclophosphamide is an option for severe pneumonitis, it is typically reserved for cases that are refractory to both steroids and second-line agents (like infliximab or MMF). It is not usually the immediate *next* step after steroid failure unless there are contraindications to TNF blockers or MMF.\n*   Option C (Switch to dexamethasone 40 mg daily): The patient is already on high-dose methylprednisolone. Switching to another steroid is unlikely to be effective for steroid-refractory disease; a distinct mechanism of immunosuppression is required.\n*   Option D (Begin plasma exchange therapy): This is not a standard treatment for CIP.\n*   Option E (Add tocilizumab 8 mg/kg IV): While IL-6 inhibitors like tocilizumab are used for cytokine release syndrome and are being investigated/used for some irAEs (especially if infliximab-refractory), infliximab remains the more established standard of care in current guidelines for this scenario.\n\nTherefore, adding infliximab is the most appropriate next step.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_deepseek-v3.2_p01", "question_id": "ABMS20260101_deepseek-v3.2_p01-010", "question": "A 70-year-old man with atrial fibrillation on apixaban (non-valvular) presents with acute onset of right-sided weakness and aphasia 4 hours after symptom onset. NIHSS is 15. CT head shows no hemorrhage. He is not a candidate for IV tPA due to anticoagulation. CT angiography shows a left M1 MCA occlusion. The most appropriate acute intervention is:", "options": ["Administer IV tPA after checking an INR and anti-Xa level", "Proceed directly to mechanical thrombectomy without thrombolysis", "Administer IV protamine to reverse apixaban, then give IV tPA", "Administer andexanet alfa, then give IV tPA", "Initiate IV heparin drip and observe for neurological improvement"], "answer": "B", "answer_index": 1, "explanation": "For patients with acute ischemic stroke and large vessel occlusion (LVO) who are not candidates for IV tPA, mechanical thrombectomy is the standard of care if performed within 24 hours of last known well and meeting other criteria (like NIHSS ≥6). Direct thrombectomy is non-inferior to bridging therapy (tPA + thrombectomy). Reversing anticoagulation to give tPA (C, D) delays definitive therapy and adds bleeding risk. Giving tPA on top of therapeutic anticoagulation (A) is contraindicated.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "topics_mapped", "source_label_raw": "Neurology", "source_quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "source_question_id": "20251205T082731900Z_deepseek-v3.2_seed123-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251205T082731900Z_deepseek-v3.2_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251205T082731900Z_deepseek-v3.2_seed123.jsonl", "pred": "B", "model_outputs": "Here is the step-by-step reasoning for the correct answer:\n\n1.  Patient Assessment: The patient has an acute ischemic stroke with a severe neurological deficit (NIHSS 15). The time of onset is 4 hours, which is within the standard treatment window for acute interventions.\n2.  Contraindication to IV Thrombolysis (tPA): The patient is taking apixaban (a Direct Oral Anticoagulant, DOAC). Current AHA/ASA guidelines state that IV tPA is generally contraindicated in patients who have received a therapeutic dose of a DOAC within the last 48 hours, as it increases the risk of intracranial hemorrhage. Even though some centers might check anti-Xa levels, the prompt states explicitly that he is \"not a candidate for IV tPA due to anticoagulation.\"\n3.  Large Vessel Occlusion (LVO): The CTA shows a left M1 MCA (middle cerebral artery) occlusion. This constitutes a large vessel occlusion.\n4.  Guideline Recommendation: For patients with an LVO in the anterior circulation who present within 6 hours of symptom onset, mechanical thrombectomy is the standard of care (Class I recommendation).\n5.  Selecting the Intervention:\n    *   Option A: Waiting for specific levels causes unnecessary delay, and the prompt already establishes he is not a candidate for tPA.\n    *   Option B: Proceeding directly to mechanical thrombectomy is the recommended course of action for patients with LVO who are ineligible for IV tPA (due to anticoagulation or other reasons).\n    *   Option C: Protamine sulfate reverses heparin, not apixaban.\n    *   Option D: Administering a reversal agent (like andexanet alfa) specifically to enable the administration of IV tPA is not currently recommended as standard practice due to unknown risks and lack of established efficacy data compared to the proven efficacy of mechanical thrombectomy alone in this scenario.\n    *   Option E: Initiating a heparin drip is not a treatment for acute ischemic stroke and would delay necessary reperfusion.\n\nTherefore, the most appropriate intervention is to bypass thrombolysis and proceed to mechanical removal of the clot.\n\nThe answer is (B)"}]